Search Results - David S. Mathai

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals by Erin Wang, David S. Mathai, Natalie Gukasyan, Sandeep Nayak, Albert Garcia-Romeu

    Published in Scientific Reports (2024-11-01)
    Get full text
    Article


  2. 2

    Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey by Sandeep M. Nayak, Sandeep M. Nayak, Hillary Jackson, Hillary Jackson, Nathan D. Sepeda, Nathan D. Sepeda, Nathan D. Sepeda, David S. Mathai, David S. Mathai, Sara So, Sara So, Abigail Yaffe, Abigail Yaffe, Hadi Zaki, Hadi Zaki, Trey J. Brasher, Matthew X. Lowe, Del R. P. Jolly, Frederick S. Barrett, Frederick S. Barrett, Frederick S. Barrett, Frederick S. Barrett, Roland R. Griffiths, Roland R. Griffiths, Roland R. Griffiths, Justin C. Strickland, Justin C. Strickland, Matthew W. Johnson, Heather Jackson, Albert Garcia-Romeu, Albert Garcia-Romeu

    Published in Frontiers in Psychiatry (2023-09-01)
    Get full text
    Article


  3. 3

    On Minimizing Risk and Harm in the Use of Psychedelics by Jules Evans, Marc Aixalà, Brian T. Anderson, William Brennan, Rebecka Bremler, Joost J. Breeksema, Lisa Burback, Abigail E. Calder, Robin L. Carhart‐Harris, Katherine Cheung, Neşe Devenot, Ingmar Gorman, Jakub Greń, Peter S. Hendricks, Brian Holoyda, Edward Jacobs, Joy Krecké, Daniel J. Kruger, David Luke, Tomislav Majić, Amy L. McGuire, Nicky J. Mehtani, David S. Mathai, Kristin Nash, Tehseen Noorani, Roman Palitsky, Oliver C. Robinson, Otto Simonsson, Elin Stahre, Michiel vanElk, David B. Yaden

    Published in Psychiatric Research and Clinical Practice (2025-03-01)
    Get full text
    Article


Search Tools: